- 全景网动态 | 2023年02月14日 17:02美国股市上涨,Contextlogic Inc上升37.34%
- finviz | 2022年09月29日 22:15Morphic Holding, Inc. (MORF) Moves 7.3% Higher: Will This Strength Last?
- finviz | 2022年09月29日 21:00Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Pay Off of Remaining Balance of its Senior Secured Notes
- finviz | 2022年09月26日 21:00Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
- finviz | 2022年09月16日 03:34Sorrento Announces the Publication in the Nature Journal Scientific Reports the Details of the Discovery of SARS-CoV-2 Neutralizing Antibodies from the G-MAB Library
- finviz | 2022年09月15日 21:00Sorrento Reports Positive Trial Results Utilizing Sofusa Lymphatic Delivery of Etanercept, Achieving Significant Improvements in Rheumatoid Arthritis Disease Measures at 50% of the Standard Dose for Patients (7 of 7) with an Inadequate Response to Subcuta
- finviz | 2022年09月08日 21:00Sorrento Therapeutics to Participate in Morgan Stanley 20th Annual Global Healthcare Conference September 12-14
- finviz | 2022年09月01日 00:01Why Sorrento Therapeutics Stock Is Marching Higher Today
- finviz | 2022年08月31日 11:21Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido
- finviz | 2022年08月25日 00:24Sorrento (SRNE) Up on Positive Result From Lung Cancer Study
- finviz | 2022年08月24日 21:452 Penny Stocks That Could Make You Filthy Rich
- finviz | 2022年08月24日 03:08Why Sorrento Therapeutics Stock Is Popping Today
- finviz | 2022年08月23日 23:58Sorrento Shares Pop After Interim Data From Lung Cancer Trial
- finviz | 2022年08月23日 21:00Sorrento Announces Significant Positive Pivotal Trial Results as Assessed by an Independent Review Committee (IRC) With Matured Long-Term (Over Three Years) Follow-Up Data of Abivertinib for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
- finviz | 2022年08月19日 21:00Sorrento Therapeutics Announces China National Medical Products Administration (NMPA) IND Clearance of STI-1558, An Oral Mpro Inhibitor for Phase I Trial In COVID-19 Patients
- finviz | 2022年08月17日 21:00Scilex Holding Company, a Sorrento Company, Announces Exclusive Product Distribution Agreement with CH Trading Group LLC to Expand Commercialization of ZTlido